Advertisement
Screener

FORRESTER RESEARCH, INC. (FORR) Restructuring Costs and Asset Impairment Charges

1.6 / 5 stars · 35/111 Roast Me

FORRESTER RESEARCH, INC. Restructuring Costs and Asset Impairment Charges

FORRESTER RESEARCH, INC. (FORR) reported Restructuring Costs and Asset Impairment Charges of $2.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-08-06

  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for the quarter ending 2026-06-30 was $2.07M, a 320.77% increase year-over-year.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for the quarter ending 2026-03-31 was $2.15M, a 42.40% increase year-over-year.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for the quarter ending 2025-12-31 was $9.84M, a 138.18% increase year-over-year.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for the quarter ending 2025-09-30 was -$111.00K, a 111.85% decline year-over-year.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for fiscal 2025 was $11.72M, a 0.42% decline from fiscal 2024.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for fiscal 2024 was $11.77M, a 11.29% decline from fiscal 2023.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for fiscal 2023 was $13.27M, a 42.17% increase from fiscal 2022.
  • FORRESTER RESEARCH, INC. restructuring costs and asset impairment charges for fiscal 2022 was $9.34M.
Period endRestructuring Costs and Asset Impairment Charges 3 monthRestructuring Costs and Asset Impairment Charges 6 monthRestructuring Costs and Asset Impairment Charges 9 monthRestructuring Costs and Asset Impairment Charges 12 month
2026-06-30$2.07M
10-Q · filed 2026-08-06
$4.21M
10-Q · filed 2026-08-06
$14.05M
derived: sum of 3 quarters · filed 2026-08-06
$13.94M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$2.15M
10-Q · filed 2026-05-08
$11.98M
derived: sum of 2 quarters · filed 2026-05-08
$11.87M
derived: sum of 3 quarters · filed 2026-05-08
$12.36M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$9.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$9.73M
derived: sum of 2 quarters · filed 2026-03-13
$10.22M
derived: sum of 3 quarters · filed 2026-08-06
$11.72M
10-K · filed 2026-03-13
2025-09-30-$111.00K
10-Q · filed 2025-11-10
$380.00K
derived: sum of 2 quarters · filed 2026-08-06
$1.89M
10-Q · filed 2025-11-10
$6.02M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$491.00K
10-Q · filed 2026-08-06
$2.00M
10-Q · filed 2026-08-06
$6.13M
derived: sum of 3 quarters · filed 2026-08-06
$7.07M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.51M
10-Q · filed 2026-05-08
$5.64M
derived: sum of 2 quarters · filed 2026-05-08
$6.57M
derived: sum of 3 quarters · filed 2026-05-08
$6.66M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$4.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$5.07M
derived: sum of 2 quarters · filed 2026-03-13
$5.15M
derived: sum of 3 quarters · filed 2026-03-13
$11.77M
10-K · filed 2026-03-13
2024-09-30$937.00K
10-Q · filed 2025-11-10
$1.02M
derived: sum of 2 quarters · filed 2025-11-10
$7.64M
10-Q · filed 2025-11-10
$8.78M
derived: sum of 4 quarters · filed 2026-03-13
2024-06-30$82.00K
10-Q · filed 2025-08-05
$6.71M
10-Q · filed 2025-08-05
$7.84M
derived: sum of 3 quarters · filed 2026-03-13
$7.86M
derived: sum of 4 quarters · filed 2026-03-13
2024-03-31$6.62M
10-Q · filed 2025-05-12
$7.76M
derived: sum of 2 quarters · filed 2026-03-13
$7.78M
derived: sum of 3 quarters · filed 2026-03-13
$18.31M
derived: sum of 4 quarters · filed 2026-03-13
2023-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13
$1.15M
derived: sum of 2 quarters · filed 2026-03-13
$11.68M
derived: sum of 3 quarters · filed 2026-03-13
$13.27M
10-K · filed 2026-03-13
2023-09-30$19.00K
10-Q · filed 2024-11-08
$10.55M
derived: sum of 2 quarters · filed 2024-11-08
$12.14M
10-Q · filed 2024-11-08
$21.48M
derived: sum of 4 quarters · filed 2025-03-07
2023-06-30$10.53M
10-Q · filed 2024-08-05
$12.12M
10-Q · filed 2024-08-05
$21.46M
derived: sum of 3 quarters · filed 2025-03-07
$21.46M
derived: sum of 4 quarters · filed 2025-03-07
2023-03-31$1.59M
10-Q · filed 2024-05-03
$10.92M
derived: sum of 2 quarters · filed 2025-03-07
$10.92M
derived: sum of 3 quarters · filed 2025-03-07
$10.92M
derived: sum of 4 quarters · filed 2025-03-07
2022-12-31$9.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07
$9.34M
derived: sum of 2 quarters · filed 2025-03-07
$9.34M
derived: sum of 3 quarters · filed 2025-03-07
$9.34M
10-K · filed 2025-03-07
2022-09-30$0.00
10-Q · filed 2023-11-08
$0.00
derived: sum of 2 quarters · filed 2023-11-08
$0.00
10-Q · filed 2023-11-08
2022-06-30$0.00
10-Q · filed 2023-08-09
$0.00
10-Q · filed 2023-08-09
2022-03-31$0.00
10-Q · filed 2023-05-09
2021-12-31$0.00
10-K · filed 2024-03-08
2020-12-31$0.00
10-K · filed 2023-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
PAYCHEX INC (PAYX)United States$36.157B25.11